O-acetylated sialic acids and their role in immune defense

Advances in Experimental Medicine and Biology

Volumn 705, Issue , 2011, Pages 525-548

  Schauer, Roland ^a   Srinivasan, G Vinayaga ^b   Wipfler, Dirk ^b   Kniep, Bernhard ^b   Schwartz Albiez, Reinhard ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

Ganglioside O acetylated GD3; Immunoregulation; Lymphocytes; Sialate O acetylesterases; Sialic acid O acetylation; Virulence

Indexed keywords

CD22 ANTIGEN; ESTERASE; GANGLIOSIDE GD3; LECTIN; LYASE; MUCIN; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; SIALIC ACID DERIVATIVE; SIALIDASE; SIALOGLYCOPROTEIN; 7 O ACETYL GD3 GANGLIOSIDE; 7-O-ACETYL-GD3 GANGLIOSIDE; 9 O ACETYL GD3 GANGLIOSIDE; 9-O-ACETYL-GD3 GANGLIOSIDE; GANGLIOSIDE; GANGLIOSIDE, GD3; LEUKOCYTE ANTIGEN;

ACETYLATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BIODEGRADATION; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CARBOHYDRATE SYNTHESIS; CARBOHYDRATE TRANSPORT; CATABOLISM; CELL INTERACTION; CELLULAR IMMUNITY; CONFERENCE PAPER; ENZYME ACTIVITY; GLYCOBIOLOGY; HUMAN; IMMUNITY; IMMUNOREGULATION; LIGAND BINDING; MAMMAL CELL; MOLECULAR RECOGNITION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; STRUCTURE ACTIVITY RELATION; TUMOR ESCAPE; VIRUS ATTACHMENT; ANIMAL; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; T LYMPHOCYTE;

ACETYLATION; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BACTERIAL INFECTIONS; CARBOHYDRATE CONFORMATION; GANGLIOSIDES; HUMANS; IMMUNITY, INNATE; MODELS, MOLECULAR; NEURAMINIDASE; SIALIC ACIDS; T-LYMPHOCYTES;

EID: 80054018708     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7877-6_28     Document Type: Conference Paper

References (102)

1. Angata T, Varki A (2002) Chemical diversity in the sialic acids and related a-keto acids: an evolutionary perspective. Chem Rev 102:439-469
2. Schauer R, Kamerling JP (1997) Chemistry, biochemistry and biology of sialic acids. In: Montreuil J, Vliegenthart JFG, Schachter H (eds) Glycoproteins II. Elsevier, Amsterdam, pp 243-402
3. Corfield AP, Ferreira do Amaral C, Wember M, Schauer R (1976) The metabolism of O-acyl-W-acylneuraminic acids. Biosynthesis of O-acylated sialic acids in bovine and equine submandibular glands. Eur J Biochem 68:597-610
4. Lrhorfi LA, GSrinivasan GV, Schauer R (2007) Properties and partial purification of sialate-O-acetyltransferase from bovine submandibular glands. Biol Chem 388:297-306
5. Claus H, Borrow R, Achtmann M, Morelli G, Kantelberg C, Longworth E, Frosch M, Vogel U (2004) Genetics of capsule O-acetylation in serogroup C, W-135 and Y. meningococci. Mol Microbiol 51:227-239
6. Deszo EL, Steenbergen SM, Freedberg DI, Vimr ER (2005) Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus. Proc Natl Acad Sci USA 102:5564-5569
7. Steenbergen SM, Lee YC, Vann WF, Vionett J, Wright LF, Vimr ER (2006) Separate pathways for O acetylation of polymeric and monomeric sialic acids and identification of sialyl O-acetyl esterase in Escherichia coli K1. J Bacteriol 188:6195-6206
8. Lewis AL, Hensler ME, Varki A, Nizet V (2006) The group B streptococcal sialic acid O-acetyltransferase is encoded by neuD, a conserved component of bacterial sialic acid bio-synthetic gene clusters. J Biol Chem 281:11186-11192
9. King MR, Vimr RP, Steenbergen SM, Spanjaard L, Plunkett G III, Blattner FR, Vimr ER (2007) Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation. J Bacteriol 189:6447-6456
10. Tiralongo J, Schauer R (2004) The enigma of enzymatic sialic acid O-acetylation. Trends Glycosci Glycotechnol 16:1-15
11. Schauer R (2004) Victor Ginsburg's influence on my research of the role of sialic acids in biological recognition. Arch Biochem Biophys 426:132-141
12. Schauer R (2007) The diversity of sialic acids and their interplay with lectins. In: Sansom C, Markman O (eds) Glycobiology. Scion Publishing Ltd, Bloxham, pp 136-149
13. Schauer R, Schmid H, Pommerencke J, Iwersen M, Kohla G (2001) Metabolism and role of O-acetylated sialic acids. In: Wu AM (ed) The molecular immunology of complex carbo-hydrates-2. Kluwer Academic/Plenum, New York
14. Reuter G, Schauer R (1994) Determination of sialic acids. Methods Enzymol 230:168-199
15. Schauer R, Shukla AK (2008) Isolation and properties of two sialate-O-acetylesterases from horse liver with 4-and 9-O-acetyl specificities. Glycoconj J 25:625-632
16. Kamerling JP, Vliegenthart JFG, Versluis C, Schauer R (1975) Identification of O-acetylated W-acylneuraminic acids by mass spectrometry. Carbohydr Res 41:7-17
17. Varki NM, Varki A (2007) Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 87:851-857
18. Schauer R, Faillard H (1968) Zur Wirkungsspezifitat der Neuraminidase. Das Verhalten isomerer W, O-Diacetyl-neuraminsaureglykoside im Submaxillarismucin von Pferd und Rind bei Einwirkung bakterieller Neuraminidase. Hoppe-Seyler's Z Physiol Chem 349:961-968
19. Reuter G, Pfeil R, Stoll S, Schauer R, Kamerling JP, Versluis C, Vliegenthart JFG (1983) Identi-fication of new sialic acids derived from glycoprotein of bovine submandibular gland. Eur J Biochem 134:139-143
20. Corfield T (1992) Bacterial sialydases -roles in pathogenicity and nutrition. Glycobiology 2:509-521
21. Corfield AP, Myerscough N, Warren BF, Durdey P, Paraskeva C, Schauer R (1999) Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconj J 16:307-317
22. Shen Y, Kohla G, Lrhorfi AL, Sipos B, Kalthoff H, Gerwig GJ, Kamerling JP, Schauer R, Tiralongo J (2004) O-Acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma. Eur J Biochem 271:281-290
23. Srinivasan GV, Schauer R (2009) Assays of sialate O-acetyltransferases and sialate esterases. Glycoconj J 26:935-944
24. Shen Y, Tiralongo J, Iwersen M, Sipos B, Kalthoff H, Schauer R (2002) Characterization of the sialate-7(9)-O-acetyltransferase from the microsomes of human colonic mucosa. Biol Chem 383:307-317
25. Mandal C, Srinivasan GV, Chowdhury S, Chandra S, Mandal C, Schauer R, Mandal C (2009) High level of sialate-O-acetyltransferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): enzyme characterization and correlation with disease status. Glycoconj J 26:57-73
26. Manzi AE, Sjoberg ER, Diaz S, Varki A (1990) Biosynthesis and turnover of O-acetyl and W-acetyl groups in the gangliosides of human melanoma cells. J Biol Chem 265:13091-13103
27. Higa HH, Butor C, Diaz S, Varki A (1989) O-acetylation and de-O-acetylation of sialic acids. O-acetylation of sialic acids in the rat liver Golgi apparatus involves an acetyl intermediate and essential histidine and lysine residues -a transmembrane reaction? J Biol Chem 264:19427-19434
28. Diaz S, Higa HH, Hayes BK, Varki A (1989) O-Acetylation and de-O-acetylation of sialic acids. J Biol Chem 264:19416-19426
29. Iwersen M, Dora H, Kohla G, Gasa S, Schauer R (2003) Solubilisation and properties of the sialate-4-O-acetyl-transferase from guinea pig liver. Biol Chem 384:1035-1047
30. Houliston RS, Endtz HP, Yuki N, Li J, Jarrell HC, Koga M, van Belkum A, Karwaski MF, Wakarchuk WW, Gilbert M (2006) Identification of a sialate-O-acetyltransferase from Campylobacter jejuni: demonstration of direct transfer to the C9 position of terminal a-2, 8-linked sialic acid. J Biol Chem 281:11480-11486
31. Bergfeld AK, Claus H, Vogel U, Muhlenhoff M (2007) Biochemical characterization of the polysialic acid-specific O-acetyltransferase NeuO of Escherichia coli K1. J Biol Chem 282:22217-22227
32. Schauer R, Casals-Stenzel J, Corfield AP, Veh RW (1988) Subcellular site of the biosynthesis of O-acetylated sialic acids in bovine submandibular gland. Glycoconj J 5:257-270
33. Kamerling JP, Schauer R, Shukla AK, Stoll S, van Halbeek H, Vliegenthart JFG (1987) Migration of O-acetyl groups in W, O-acetylneuraminic acids. Eur J Biochem 162:601-607
34. Schauer R, Reuter G, Stoll S (1988) Sialate O-acetylesterases -key enzymes in sialic acid catabolism. Biochimie 70:1511-1519
35. Smits SL, Gerwig GJ, van Vliet ALW, Lissenberg A, Briza P, Kamerling JP, Vlasak R, de Groot RJ (2005) Nidovirus sialate-O-acetylesterases. Evolution and substrate specificity of coronaviral and toroviral receptor-destroying enzymes. J Biol Chem 280:6933-6941
36. Herrler G, Rott R, Klenk HD, Muller HP, Shukla AK, Schauer R (1985) The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J 4:1503-1506
37. Harms G, Reuter G, Corfield AP, Schauer R (1996) Binding specificity of influenza C-virus to variably O-acetylated glycoconjugates and its use for histochemical detection of W-acetyl-9-O-acetylneuraminic acid in mammalian tissues. Glycoconj J 13:621-630
38. Robbe C, Capon C, Maes E, Rousset M, Zweibaum A, Zanetta JP, Michalski JC (2003) Evidence of regio-specific glycosylation in human intestinal mucins. J Biol Chem 278:46337-46368
39. Miyagi T, Wada T, Yamaguchi K, Hata K (2004) Sialidase and malignancy: a mini review. Glycoconj J 20:189-198
40. Corfield AP, Michalski JC, Schauer R (1981) The substrate specificity of sialidases from micro-organisms and mammals. In: Tettamanti G, Durand P, Di Donato S (eds) Sialidases and sialidoses, perspectives in inherited metabolic diseases, vol 4. Edi Ermes, Milan, pp 3-70
41. Roggentin P, Schauer R, Hoyer LL, Vimr ER (1993) The sialidase superfamily and its spread by horizontal gene transfer. Mol Microbiol 9:915-921
42. Schauer R (2004) Sialic acids: fascinating sugars in higher animals and man. Zoology 107:49-64
43. Kleineidam RG, Furuhata K, Ogura H, Schauer R (1990) 4- Methylumbelliferyl-a-glycosides of partially O-acetylated W-acetylneuraminic acids as substrates of bacterial and viral siali-dases. Biol Chem Hoppe-Seyler 371:715-719
44. Schauer R (1985) Sialic acids and their roles as biological masks. Trends Biochem Sci 10:357-360
45. Kiehne K, Schauer R (1992) The influence of a-and b-galactose residues and sialic acid O-acetyl groups of rat erythrocytes on the interaction with peritoneal macrophages. Biol Chem Hoppe-Seyler 373:1117-1123
46. Engstler M, Schauer R, Brun R (1995) Distribution and developmentally regulated trans-sialidases in the Kineto-plastida and characterization of a shed trans-sialidase activity from procyclic Trypanosoma congolense. Acta Trop 59:117-129
47. Engstler M, Reuter G, Schauer R (1992) Purification and characterization of a novel sialidase in procyclic culture forms of Trypanosoma brucei. Mol Biochem Parasitol 54:21-30
48. Shugaba A, Umar I, Omage J, Ibrahim ND, Andrews J, Ukoha AI, Saror DI, Esievo KA (1994) Biochemical differences (O-acetyl and glycolyl groups) in erythrocyte surface sialic acids trypanotolerant N'dama and trypano-susceptible Zebu cattle. J Comp Pathol 110:91-95
49. Harduin-Lepers A, Mollicone R, Delannoy P, Oriol R (2005) The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology 15:805-817
50. Severi E, Hood DW, Thomas GH (2007) Sialic acid utilization by bacterial pathogens. Microbiology 153:2817-2822
51. Rinninger A, Richet C, Pons A, Kohla G, Schauer R, Bauer HC, Zanetta JP, Vlasak R (2006) Localisation and distribution of O-acetylated W-acetylneuraminic acids, the endogenous substrates of the hemagglutinin-esterase of murine coronaviruses, in mouse tissue. Glycoconj J 23:73-84
52. Higa HH, Rogers GN, Paulson JC (1985) Influenza virus hemagglutinins differentiate between receptor deter-minants bearing W-acetyl-, W-glycolyl-, and W, O-diacetylneuraminic acids. Virology 144:279-282
53. Shi WX, Chammas R, Varki NM, Powell L, Varki A (1996) Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to I-type lectins, and tissue homing. J Biol Chem 271:31526-31532
54. Klotz FW, Orlandi PA, Reuter G, Cohen SJ, Haynes JD, Schauer R, Howard RJ, Palese P, Miller LH (1992) Binding of Plasmodium falciparum 175 kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires W-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol 51:49-54
55. Kelm S, Schauer R (1997) Sialic acids in molecular and cellular interactions. Int Rev Cytol 175:137-240
56. Crocker PR (2005) Siglecs in innate immunity. Curr Opin Pharmacol 5:1-7
57. Varki A, Angata T (2006) Siglecs -the major subfamily of I-type lectins. Glycobiology 16:1R-27R
58. Yu H, Chen X (2007) Carbohydrate post-glycosylational modifications. Org Biomol Chem 5:865-872
59. Iijima R, Takahashi H, Ikegami S, Yamazaki M (2007) Characterization of the reaction between sialic acid (W-acetylneuraminic acid) and hydrogen peroxide. Biol Pharm Bull 30:580-582
60. Ogasawara Y, Namai T, Yoshino F, Lee MCI, Ishii K (2007) Sialic acid is an essential moiety of mucin as a hydroxyl radical scavenger. FEBS Lett 581:2473-2477
61. Tanaka K, Tokumaru S, Kojo S (1997) Possible involvement of radical reactions in desialyla-tion of LDL. FEBS Lett 413:202-204
62. Klein A, Krishna M, Varki NM, Varki A (1994) 9-O-Acetyl-sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase. Proc Natl Acad Sci USA 91:7782-7786
63. Born GVR, Palinski W (1985) Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exp Pathol 66:543-549
64. Orskov F, Orskov I, Sutton A, Schneerson R, Lin W, Egan W, Hoff GE, Robbins JB (1979) Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J Exp Med 149:669-685
65. King MR, Steenbergen SM, Vimr ER (2007) Going for baroque at the Escherichia coli K1 cell surface. Trends Microbiol 15:196-202
66. Schwartz-Albiez R (2002) Carbohydrates and lectins. In: Mason D et al (eds) Leucocyte typing VII. Oxford University Press, Oxford, pp 149-164
67. Schwartz-Albiez R, Claus C, Kniep B (2002) CD60 Workshop report. In: Mason D et al (eds) Leucocyte typing VII. Oxford University Press, Oxford, pp 185-188
68. Bergelson LD, Dyatlovitskaya EV, Klyuchareva TE, Kryukova EV, Lemenovskaya AF, Matveeva VA, Sinitsyna EV (1989) The role of glycosphingolipids in natural immunity: gangliosides modulate the cytotoxicity of natural killer cells. Eur J Immunol 19:1979-1983
69. Grayson G, Ladisch S (1992) Immunosuppression by human gangliosides II. Carbohydrate structure and inhibition of human NK activity. Cell Immunol 139:18-29
70. Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR (2003) Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur J Immunol 33:1642-1648
71. Hubl U, Ishida H, Kiso M, Hasegawa A, Schauer R (2000) Studies on the specificity and sensitivity of the influenza C virus binding assay for O-acetylated sialic acids and its application to human melanomas. J Biochem 127:1021-1031
72. Park JE, Wu DY, Prednes M, Lu SX, Ragupathi G, Schrantz N, Chapman PB (2008) Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand. Immunology 123:145-155
73. Pequet-Navarro J, Portouch M, Popa I, Berthier O, Schmitt D, Portoukalian J (2003) Gangliosides from human melanoma tumors impair dendritic cell differentiation from mono-cytes and induce their apoptosis. J Immunol 170:3488-3494
74. Ravindranath MH, Muthugounder S, Presser N (2008) Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient. Melanoma Res 18:47-55
75. Fahr C, Schauer R (2001) Detection of sialic acids and gangliosides with special reference to 9-O-acetylated species in basaliomas and normal human skin. J Invest Dermatol 116:254-260
76. Gocht A, Rutter G, Kniep B (1998) Changed expression of 9-O-acetyl GD3 (CDw60) in benign and atypical pro-liferative lesions and carcinomas of the human breast. Histochem Cell Biol 110:217-229
77. Mann B, Klussmann E, Vandamme-Feldhaus V, Iwersen M, Hanski ML, Riecken EO, Buhr HJ, Schauer R, Kim YS, Hanski C (1997) Low O-acetylation of sialyl-Lex contributes to its overexpression in colon carcinoma metastases. Int J Cancer 72:258-264
78. Corfield AP, Wagner SA, Clamp JR, Kriaris MS, Hoskins LC (1992) Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, W-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect Immun 60:3971-3978
79. Schauer R, Stoll S, Reuter G (1991) Differences in the amount of W-acetyl-and W-glycoloyl-neuraminic acids, as well as O-acylated sialic acids, of fetal and adult bovine tissues. Carbohydr Res 213:353-359
80. Diaz AO, Garcia AM, Goldemberg AL (2008) Glycoconjugates in the mucosa of the digestive tract of Cynoscion guatucupa: a histochemical study. Acta Histochem 110:76-85
81. Corfield AP, Donapaty SR, Carrington SD, Hicks SJ, Schauer R, Kohla G (2005) Identification of 9-O-acetyl-W-acetylneuraminic acid in normal canine pre-ocular tear film secreted mucins and its depletion in Keratoconjunctivitis sicca. Glycoconj J 22:409-416
82. Boehm G, Stahl B (2007) Oligosaccharides from milk. J Nutr 137:847S-849S
83. Herrler G, Reuter G, Rott R, Klenk HD, Schauer R (1987) W-Acetyl-9-O-acetylneuraminic acid, the receptor determinant for influenza C virus, is a differentiation marker on chicken erythrocytes. Biol Chem Hoppe-Seyler 368:451-454
84. Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7:255-266
85. Ariga T, Suetake K, Nakane M, Kubota M, Usuki S, Kawashima I, Yu RK (2008) Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors. Neurosignals 16:226-234
86. Pal S, Chatterjee M, Bhattacharya DK, Bandhyopadhyay S, Mandal C (2000) Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia. Glycobiology 10:539-549
87. Schwartz-Albiez R, Laban S, Eichmuller S, Kirschfink M (2008) Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy? Autoimmun Rev 7:491-495
88. Bowes T, Wagner ER, Boffey J, Nicholl D, Cochrane L, Benboubetra M, Conner J, Furukawa K, Furukawa K, Willison HJ (2002) Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barre syndrome. Infect Immun 70:5008-5018
89. Kniep B, Flegel WA, Northoff H, Rieber EP (1993) CDw60 glycolipid antigens of human leukocytes: structural characterization and cellular distribution. Blood 82:1776-1786
90. Kniep B, Claus C, Peter-Katalinic J, Monner DA, Dippold W, Nimtz M (1995) 7-O-acetyl-GD3 in human T-lymphocytes is detected by a specific T-cell-activating monoclonal antibody. J Biol Chem 270:30173-30180
91. Fox DA, He X, Abe A, Hollander T, Li LL, Kan L, Friedman AW, Shimizu Y, Shayman JA, Kozarsky K (2001) The T lymphocyte structure CD60 contains a sialylated carbohydrate epitope that is expressed on both gangliosides and glycoproteins. Immunol Invest 30:67-85
92. Rieber EP, Rank G (1994) CDw60: a marker for human CD8+ T helper cells. J Exp Med 179:1385-1390
93. Erdmann M, Wipfler D, Merling A, Cao Y, Claus C, Kniep B, Sadick H, Bergler W, Vlasak R, Schwartz-Albiez R (2006) Differential surface expression and possible function of 9-O-and 7-O-acetylated GD3 (CD60 b and c) during activation and apoptosis of human tonsillar B and T lymphocytes. Glycoconj J 23:627-638
94. Vater M, Kniep B, Gross HJ, Claus C, Dippold W, Schwartz-Albiez R (1997) The 9-O-acetylated disialosyl carbohydrate sequence of CDw60 is a marker on activated human B lymphocytes. Immunol Lett 59:151-157
95. Claus C, Schlaak J, Dittmayer M, Meyer zum Buschenfeld K, Dippold W (1994) Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells. Eur J Immunol 24:1208-1212
96. Strasser P, Unger U, Strobl B, Vilas U, Vlasak R (2004) Recombinant viral sialate-O-acetylesterases. Glycoconj J 20:551-561
97. Garcia-Ruiz C, Colell A, Morales A, Calvo M, Enrich C, Fernandez-Checa JC (2002) Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-alpha. J Biol Chem 277:36443-36448
98. Garofalo T, Tinari A, Matarrese P, Giammarioli AM, Manganelli V, Ciarlo L, Misasi R, Sorice M, Malorni W (2007) Do mitochondria act as "cargo boats" in the journey of GD3 to the nucleus during apoptosis? FEBS Lett 581:3899-3903
99. Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G, Testi R (2000) GD3 ganglioside directly targets mitochondria in a bc1-2-controlled fashion. FASEB J 14:2047-2054
100. Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC (2000) Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J 14:847-858
101. Malisan F, Franchi L, Tomassini B, Ventura N, Condo I, Rippo MR, Rufini A, Liberati L, Nachtigall C, Kniep B, Testi R (2002) Acetylation supresses the proapoptotic activity of GD3 ganglioside. J Exp Med 196:1535-1541
102. Kniep B, Kniep E, Ozkucur N, Barz S, Bachmann M, Malisan F, Testi R, Rieber EP (2006) 9-O-acetyl GD3 protects tumor cells from apoptosis. Int J Cancer 119:67-73